Target intelligence / Profile preview

Ribosomal protein L36 pseudogene 20 (RPL36P20)

Target: RPL36P20
Molecular classification: Other (Processed pseudogene)

Overview

Ribosomal protein L36 pseudogene 20 (RPL36P20) is a *human processed pseudogene* closely related in sequence to ribosomal protein L36 (RPL36), a component of the large (60S) ribosomal subunit involved in protein synthesis[3][5][7]. As a pseudogene, RPL36P20 does not encode a functional protein and is not part of any canonical molecular pathway. While some pseudogenes have been implicated in non-coding RNA regulatory activities, such as acting as microRNA decoys or influencing the expression of their parental gene at the RNA level, there is no published evidence for a specific biological or disease role, nor for any drug targeting or use as a biomarker, with respect to RPL36P20[6]. The gene is annotated as a non-protein coding unit with no therapeutic target relevance.

Other names: RPL36P20ribosomal protein L36 pseudogene 20

Biological functions

Other (no direct protein-coding function; possible RNA-level regulatory capacity as described for some pseudogenes, but not confirmed for RPL36P20 specifically)

Disease associations

Other (no disease role established; general pseudogene literature suggests possible involvement in gene regulatory networks via microRNA decoy activity but this has not been specifically shown for RPL36P20)

Beyond the preview

Go deeper on Ribosomal protein L36 pseudogene 20 (RPL36P20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36 pseudogene 20 (RPL36P20).

Explore the full profile